Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

6.24
Delayed Data
As of 10:15am ET
 +0.08 / +1.30%
Today’s Change
3.70
Today|||52-Week Range
9.25
+9.09%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close6.16
Today’s open6.20
Day’s range6.20 - 6.25
Volume3,687
Average volume (3 months)49,704
Market cap$142.1M
Dividend yield--
Data as of 10:15am ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-11.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+33.56%
P/E ratioNM
Price/Sales5.42
Price/Book2.90

Competitors

 Today’s
change
Today’s
% change
CTICCTi Biopharma Corp-0.03-5.50%
ATHXAthersys Inc-0.03-1.86%
XENEXenon Pharmaceutical...+0.04+0.57%
RDHLRedhill Biopharma Lt...+0.03+0.26%
Data as of 10:31am ET, 12/07/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$20.1M
Annual profit (last year)-$12.8M
Net profit margin-63.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs